Eurofins Technologies has launched the GSD NovaPrime® SARS-CoV-2 Mplex FLA kit for Sanger sequencing instruments. Many of these instruments have been installed worldwide, meaning this launch could help boost throughput testing capacities. More than 2,000 samples can be processed in a day with the help of this assay, with the test kit providing sensitivity and time to results similar to qRT-PCR testing.
The US Food and Drug Administration (FDA) has authorised the first antibody test for point-of-care settings in the US. The Assure Tech Fastep® COVID-19 IgG/IgM Rapid Test Device will be distributed by Carolina Liquid Chemistries, and will be conducted with fingerstick whole blood samples only at certified point-of-care settings.
Fluidigm Corporation has announced a partnership with Healthvana to provide clinical laboratory customers utilizing the Fluidigm® saliva-based Advanta™ Dx SARS-CoV-2 RT-PCR Assay with the option to deliver test results faster via Healthvana’s mobile platform. Ramin Bastani, the CEO of Healthvana stated that on an average, patients were able to view their results within 30 minutes.
Quansys Biosciences has received FDA EUA for its IgG antibody test. A positive IgG antibody result helps detect patients who have been exposed or infected with the SARS-CoV-2 virus, and show adaptive immune response when patients are recovering from the infection.